2010
DOI: 10.1124/jpet.110.175117
|View full text |Cite
|
Sign up to set email alerts
|

meso-Transdiene Analogs Inhibit Vesicular Monoamine Transporter-2 Function and Methamphetamine-Evoked Dopamine Release

Abstract: Lobeline, a nicotinic receptor antagonist and neurotransmitter transporter inhibitor, is a candidate pharmacotherapy for methamphetamine abuse. meso-Transdiene (MTD), a lobeline analog, lacks nicotinic receptor affinity, retains affinity for vesicular monoamine transporter 2 (VMAT2), and, surprisingly, has enhanced affinity for dopamine (DA) and serotonin transporters [DA transporter (DAT) and serotonin transporter (SERT), respectively]. In the current study, MTD was evaluated for its ability to decrease metha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
18
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
2

Relationship

4
3

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 32 publications
(39 reference statements)
2
18
0
Order By: Relevance
“…Considerable attention has been given to positive rewarding effects associated with MA addiction (Beckmann et al, 2010;Horton et al, 2011;Kamens et al, 2005;Mahler et al, 2013;Meyer et al, 2011;Mizoguchi et al, 2004;Shabani et al, 2011Shabani et al, , 2012aWheeler et al, 2009), whereas aversive effects that could limit intake have been given less consideration (Harrod et al, 2010;Pringle et al, 2008;Shabani et al, 2011Shabani et al, , 2012bWheeler et al, 2009). Greater Figure 3 (a) Methamphetamine (MA) consumption differs by Taar1 genotype.…”
Section: Discussionmentioning
confidence: 99%
“…Considerable attention has been given to positive rewarding effects associated with MA addiction (Beckmann et al, 2010;Horton et al, 2011;Kamens et al, 2005;Mahler et al, 2013;Meyer et al, 2011;Mizoguchi et al, 2004;Shabani et al, 2011Shabani et al, , 2012aWheeler et al, 2009), whereas aversive effects that could limit intake have been given less consideration (Harrod et al, 2010;Pringle et al, 2008;Shabani et al, 2011Shabani et al, , 2012bWheeler et al, 2009). Greater Figure 3 (a) Methamphetamine (MA) consumption differs by Taar1 genotype.…”
Section: Discussionmentioning
confidence: 99%
“…Samples were filtered rapidly through Whatman GF/B filters using the cell harvester and washed three times with assay buffer containing 2 mM MgSO 4 in the absence of ATP. Radioactivity retained by the filters was determined as described under Rat coronal striatal slices of 0.5-mm thickness were prepared and incubated in Krebs' buffer, containing 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 1.0 mM NaH 2 PO 4 , 1.3 mM CaCl 2 , 11.1 mM ␣-D-glucose, 25 mM NaHCO 3 , 0.11 mM L-ascorbic acid, and 0.004 mM EDTA, pH 7.4, saturated with 95% O 2 /5% CO 2 at 34°C in a metabolic shaker for 60 min (Horton et al, 2011). Each slice was transferred to a glass superfusion chamber and superfused with Krebs' buffer at 1 ml/min for 60 min before sample collection.…”
Section: Animalsmentioning
confidence: 99%
“…Analog-induced inhibition of [ 3 H]DTBZ binding, a high-affinity ligand for VMAT2, was determined using modifications of a previously published method (Horton et al, 2011). Rat whole brain (excluding cerebellum) was homogenized in 20 ml of ice-cold 0.32 M sucrose solution with 10 up-and-down strokes of a Teflon pestle homogenizer (clearance ϳ0.008 inch).…”
Section: Animalsmentioning
confidence: 99%
See 2 more Smart Citations